This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (20)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Quality of Care, Other  • Adverse Effects  • Medication Error  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Nancy M. Allen LaPointe, PharmD; James G. Jollis, MD

Arch Intern Med. 2003;163:1461-1466.

Background  The Institute of Medicine's report To Err Is Human: Building a Safer Health System recommends pharmacist participation in patient rounds as an immediate approach to reducing medical errors. In the same report and in prior publications, cardiovascular drugs have been commonly associated with severe adverse drug events.

Methods  We systematically reviewed the experience of a clinical pharmacist on the cardiology wards between September 1, 1995, and February 18, 2000. We classified medication errors according to the type of error, medications involved, personnel involved, stages of drug administration involved, and time of year most frequently associated with errors.

Results  Among 14 983 pharmacist interventions, 4768 were related to medication errors, or 24 medication errors per 100 admissions. The most common errors involved the wrong drug (36.0%) or wrong dose (35.3%), and cardiovascular medications were involved in 41.2% of the errors. Prescribers were associated with most of the errors, and the transition from outpatient to inpatient was the most common point in the system for the occurrence of these medication errors. Higher numbers of errors were also identified during the transition period of house staff, and the total number of errors increased during the study period.

Conclusions  Through the clinical pharmacist's identification and correction of medication errors, 2 areas of improvement that may reduce medication errors were identified. The first is ensuring accurate knowledge of a patient's outpatient medication regimen. The second involves improving the education and support of new interns during their initial months of training. This work exemplifies the approach recommended by the Institute of Medicine to reduce medical errors through systematic analyses rather than ascribing fault to individuals.

From the Duke Center for Education and Research on Therapeutics, Duke Clinical Research Institute, and the Division of Cardiology, Duke University Medical Center, Durham, NC. The authors have no relevant financial interest in this article.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Strategic approach for improving the medication-use process in health systems: The high-performance pharmacy practice framework
Vermeulen et al.
Am J Health Syst Pharm 2007;64:1699-1710.
ABSTRACT | FULL TEXT  

Multidisciplinary team for enhancing care for patients with acute myocardial infarction or heart failure
Coons and Fera
Am J Health Syst Pharm 2007;64:1274-1278.
ABSTRACT | FULL TEXT  

Design and Implementation of an Application and Associated Services to Support Interdisciplinary Medication Reconciliation Efforts at an Integrated Healthcare Delivery Network
Poon et al.
J. Am. Med. Inform. Assoc. 2006;13:581-592.
ABSTRACT | FULL TEXT  

Escalating polypharmacy
Gorard
QJM 2006;99:797-800.
ABSTRACT | FULL TEXT  

Reconcilable differences: correcting medication errors at hospital admission and discharge.
Vira et al.
Qual Saf Health Care 2006;15:122-126.
ABSTRACT | FULL TEXT  

Role of Pharmacist Counseling in Preventing Adverse Drug Events After Hospitalization.
Schnipper et al.
Arch Intern Med 2006;166:565-571.
ABSTRACT | FULL TEXT  

Crosswalk for the 2015 Initiative
Am J Health Syst Pharm 2005;62:1392-1393.
FULL TEXT